Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Feb 14 04:00PM ET
2.69
Dollar change
-0.01
Percentage change
-0.37
%
Index- P/E- EPS (ttm)-5.80 Insider Own5.74% Shs Outstand8.59M Perf Week0.75%
Market Cap23.11M Forward P/E1.98 EPS next Y1.36 Insider Trans0.00% Shs Float8.10M Perf Month-20.88%
Income-40.72M PEG- EPS next Q-0.95 Inst Own8.46% Short Float6.34% Perf Quarter-77.69%
Sales0.00M P/S- EPS this Y69.18% Inst Trans-18.35% Short Ratio1.78 Perf Half Y-81.77%
Book/sh8.46 P/B0.32 EPS next Y173.73% ROA-36.38% Short Interest0.51M Perf Year-84.18%
Cash/sh0.13 P/C21.01 EPS next 5Y- ROE-52.85% 52W Range2.44 - 26.75 Perf YTD-32.75%
Dividend Est.- P/FCF- EPS past 5Y20.90% ROI-62.26% 52W High-89.94% Beta1.11
Dividend TTM- Quick Ratio0.09 Sales past 5Y0.00% Gross Margin- 52W Low10.25% ATR (14)0.29
Dividend Ex-Date- Current Ratio0.41 EPS Y/Y TTM-7.44% Oper. Margin- RSI (14)37.71 Volatility7.86% 8.08%
Employees23 Debt/Eq0.00 Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price103.00
Option/ShortYes / Yes LT Debt/Eq0.00 EPS Q/Q10.20% Payout- Rel Volume0.34 Prev Close2.70
Sales Surprise- EPS Surprise4.76% Sales Q/Q- EarningsFeb 14 AMC Avg Volume288.98K Price2.69
SMA20-5.58% SMA50-14.79% SMA200-76.56% Trades Volume97,509 Change-0.37%
Date Action Analyst Rating Change Price Target Change
Dec-30-24Upgrade D. Boral Capital Hold → Buy $9
Nov-30-21Initiated Maxim Group Buy $4
Feb-14-25 04:30PM
Feb-06-25 08:55AM
Jan-08-25 08:00AM
Jan-07-25 08:08AM
07:57AM
07:50AM Loading…
Jan-06-25 07:50AM
Dec-31-24 07:10AM
Dec-30-24 09:43AM
Dec-29-24 10:50PM
Dec-27-24 05:00PM
Nov-25-24 08:03AM
Nov-22-24 09:00AM
Nov-18-24 04:05PM
Nov-15-24 01:30PM
Nov-11-24 08:45AM
04:30PM Loading…
Sep-05-24 04:30PM
08:30AM
Aug-13-24 09:30AM
04:32AM
Aug-12-24 10:53PM
05:28PM
04:22PM
08:00AM
Aug-09-24 07:30AM
Aug-08-24 05:41PM
06:59AM
Aug-05-24 08:00AM
08:00AM
Jul-18-24 07:00AM
Jul-17-24 08:00AM
11:00AM Loading…
Jul-11-24 11:00AM
08:00AM
Jul-10-24 09:10AM
Jul-07-24 09:01AM
Jun-11-24 10:50AM
May-29-24 08:30AM
May-21-24 11:42AM
11:20AM
10:58AM
07:00AM
May-14-24 10:55PM
04:05PM
May-10-24 08:30AM
Apr-30-24 04:05PM
Apr-26-24 10:43AM
08:00AM
Apr-11-24 08:30AM
Apr-04-24 08:30AM
Mar-18-24 08:30AM
Mar-12-24 10:30AM
Mar-07-24 08:30AM
Feb-26-24 07:30AM
Feb-23-24 08:30AM
Feb-15-24 09:17AM
Feb-14-24 04:30PM
08:01AM
Jan-23-24 08:30AM
Jan-02-24 08:31AM
08:30AM
Nov-14-23 08:55AM
Nov-09-23 08:30AM
Oct-31-23 08:45AM
Oct-24-23 07:30AM
Sep-21-23 09:35AM
Sep-18-23 04:30PM
Sep-13-23 04:30PM
Sep-08-23 08:00AM
Sep-06-23 04:30PM
Aug-14-23 04:15PM
Aug-10-23 08:37AM
Jul-29-23 04:16PM
Jun-26-23 08:30AM
Jun-20-23 04:09PM
08:30AM
Jun-13-23 08:30AM
May-12-23 04:30PM
May-08-23 01:42PM
May-04-23 08:00AM
Apr-24-23 09:10AM
Apr-03-23 08:00AM
Mar-30-23 08:30AM
Mar-27-23 09:52AM
Mar-13-23 09:15AM
Mar-08-23 08:30AM
Feb-10-23 04:30PM
Feb-06-23 10:30AM
Jan-17-23 10:00AM
Jan-16-23 07:09AM
Jan-11-23 08:30AM
Dec-28-22 09:35AM
Dec-22-22 04:30PM
Dec-01-22 07:30AM
Nov-21-22 08:00AM
Nov-09-22 08:30AM
Oct-18-22 08:30AM
07:59AM
Oct-06-22 04:30PM
Sep-28-22 08:30AM
Sep-23-22 06:48AM
Sep-22-22 04:30PM
Citius Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of critical care products, with a focus on oncology, anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. Its products include I/ONTAK, Mino-Lok, Halo-Lido, Mino-Wrap, and Novecite. The company was founded by Ralph Montrone on January 23, 2007 and is headquartered in Cranford, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Holuka Eugene MyronDirectorMar 13 '24Option Exercise0.012,415362,415Aug 30 04:01 PM
Webb CarolDirectorMar 04 '24Option Exercise0.0112,07118112,071Aug 30 04:01 PM